Table 2.
Levels of anti-bovine rotavirus (BoRV), anti-bovine coronavirus (BoCV) and anti-F5-adhesin (F5) antibodies in the colostrum, expressed as % of light inhibition measured by competitive ELISA, depending on the inter-booster vaccination interval (IBVI). Data are presented as median (min; max); n = number of animals with the indicated IBVI (± 2 weeks); and the % of animals with a PI ≥ 95% in brackets.
IBVI ≤ 12 months* | IBVI > 12 months* | ||
---|---|---|---|
BoRV | Vaccination group BS | 97% (57%; 99%) | 98% (60%; 99%) |
n = 37 (70%) | n = 22 (86%) | ||
Vaccination group RC | 95% (40%; 99%) | 97% (53%; 99%) | |
n = 32 (59%) | n = 34 (79%) | ||
BoCV | Vaccination group BS | 99% (94%; 99%) | 99% (88%; 100%) |
n = 37 (95%) | n = 22 (82%) | ||
Vaccination group RC | 99% (93%; 100%) | 97% (86%; 99%) | |
n = 32 (94%) | n = 34 (74%) | ||
F5 | Vaccination group BS | 98% (70%; 99%) | 98% (46%; 99%) |
n = 37 (84%) | n = 22 (77%) | ||
Vaccination group RC | 98% (74%; 100%) | 97% (69%; 99%) | |
n = 32 (88%) | n = 34 (71%) |
IBVI comprised between 10 and 19 months (± 2 weeks)